MSLN and mesothelioma: Due to the uncertainty regarding the expression and prognostic significance of MSLN in mesothelioma, we aimed to assess these factors in a cohort of patients with mesothelioma to determine which patients are suitable for anti‐MSLN targeted therapies and to assist in the design of future clinical trials.